All terms

    AI Act Technical Documentation (Annex IV)

    The information set a provider must maintain to demonstrate a high-risk AI system's compliance with Articles 8 to 15.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed July 25, 2026

    Definition

    Article 11 and Annex IV require providers of high-risk AI systems to prepare and keep up to date technical documentation covering system description, design specification, monitoring and control, risk management, training and testing data (methodology, provenance, labelling, cleaning), validation and testing procedures, cybersecurity, and the post-market monitoring plan.
    What the regulation says
    Regulation (EU) 2024/1689, adopted on 13 June 2024 and in force since 1 August 2024, establishes technical documentation requirements in Article 11 and Annex IV. Providers must prepare documentation before a high-risk AI system is placed on the market or put into service and keep it updated. It must demonstrate compliance with Articles 8 to 15 and give competent authorities and notified bodies clear, comprehensive information for assessing conformity. Annex IV specifies content covering intended purpose, system design, development methods, data provenance and preparation, validation and testing, performance limitations, human oversight, cybersecurity, risk management, changes, and the post-market monitoring plan. For MedTech AI covered by Article 6(1), Article 113 sets 2 August 2027 as the application date for that provision and its corresponding obligations. Article 11(2) requires a single technical documentation set combining AI Act information with documentation required by applicable product legislation. Relevant instruments include Regulation (EU) 2017/745 on medical devices, applicable since 26 May 2021, and Regulation (EU) 2017/746 on in vitro diagnostic medical devices, applicable since 26 May 2022, particularly their Annexes II and III. Existing device documentation therefore needs to address applicable AI Act requirements, not simply reference them.

    What this means in practice

    For medical devices, Annex IV elements fold into the MDR Annex II or IVDR Annex II technical documentation rather than sitting in a separate file. Data-governance evidence (Article 10) is the section most often underdeveloped in existing device technical files.

    Examples

    • A manufacturer developing an AI-powered diagnostic imaging system includes detailed descriptions of its architecture, data sources for training, validation protocols, and cybersecurity safeguards in its technical documentation.
    • A provider of an AI system for surgical planning ensures their technical documentation comprehensively details their risk management procedures, including identified risks, mitigation strategies, and residual risk assessment.
    • A company providing an AI system for chronic disease management includes evidence of data governance, data labelling processes, and the methodology used for testing the system's accuracy and robustness within its Annex IV documentation.
    Common pitfalls
    • •Treating Annex IV as boilerplate. Notified bodies specifically probe training-data provenance and labelling processes.

    Frequently asked questions

    No, for medical devices the Annex IV elements are intended to fold into the existing MDR Annex II or IVDR Annex II technical documentation rather than existing as a standalone parallel file. The practical approach is to map each Annex IV requirement, such as training data provenance or the post-market monitoring plan, to the corresponding section of the device technical file and ensure that section is built out to the depth the AI Act requires.
    Grouped by theme
    Cited by

    Where this term appears across MedTech Terms.

    Latest in MedTech

    Sources

    3 sources

    Every citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

    Tier 1Binding law and standards· 1Tier 2Regulator guidance and consensus· 1Tier 4Trade press and expert commentary· 1
    Link health: 3 verified· last checked 2026-06-20
    EUR-Lex·1IMDRF·1RAPS·1
    1. 1
      Regulation (EU) 2024/1689, Article 11 and Annex IV
      Tier 1 Verified
      EUR-Lexeur-lex.europa.eu
    2. 2
      IMDRF Documents
      Tier 2 Verified
      IMDRFimdrf.org
    3. 3
      RAPS Regulatory Focus
      Tier 4 Verified
      RAPSraps.org

    Inline markers like [1] jump to the matching reference above.